Roche gives Tocilizumab worth over Rs 40 crores to MoHFW - Express Pharma
Tocilizumab Shortage Continues as Pandemic Wears On
%20400%20mg_20%20mL253e948d-03f9-4810-a763-a2ce009aaf4b.GIF "Roche Products & Contact Information | MIMS Malaysia")
Roche Products & Contact Information | MIMS Malaysia
Roche Arthritis Drug Fails Covid-19 Testing - WSJ
CHMP backs expanded approval of tocilizumab | MDedge Hematology and Oncology
China backs use of Roche's Actemra for coronavirus - PMLiVE
Roche arthritis drug cuts deaths in hospitalized COVID-19 patients, study suggests | CBC News
Roche | Actemra/RoActemra (tocilizumab)
Roche rend public le brevet de son médicament contre le Covid-19
Tocilizumab, un medicament folosit pentru artrită, reduce riscul de deces la pacienții cu forme grave de COVID (studiu) | Digi24
Approval lapsed) RoActemra tocilizumab 400 mg/ 20mL concentrate for solution for infusion (Roche Germany) | Therapeutic Goods Administration (TGA)
Health System News Teamwork Tackles Tocilizumab
USTC Global on Twitter: "The mechanism of using Tocilizumab to cure severe patients of COVID-19. @NIH @CDC @DrAiLynTan #coronavirus #COVID19 #CoronavirusOutbreak #coronaviruskorea #ItalyCoronavirus #italylockdown #IranCoVidTruth #Tocilizumab https://t ...
Tocilizumab Improves Myocardial Salvage After STEMI: ASSAIL-MI | tctmd.com
FDA Advisory No.2021-2406 || Public Health Warning Against the Purchase and Use of the Unregistered Drug Product “Actemra® Tocilizumab 400 mg/ 20 mL” - Food and Drug Administration
Medicamentul Tocilizumab se dovedește eficient pentru pacienţii în stare gravă - MedicalManager.ro
Genentech moves Actemra into phase III COVID-19 trial | 2020-03-19 | BioWorld
Tocilizumab Raises GI Risks in Rheumatoid Arthritis | MedPage Today
Genentech's arthritis drug tocilizumab shows promise in Covid-19 trial
FDA approves drug to treat CRS induced by CAR T-cell therapy | MDedge Hematology and Oncology
Tocilizumab: un fármaco en monopolio para tratar COVID-19 sin eficacia probada - Salud con lupa
Roche to boost Tocilizumab supply to meet rising demand in India - The Economic Times
Actemra; coronavirus complications to be treated under Chinese approval
